Tech Company Financing Transactions
SomaLogic Funding Round
On 3/1/2016, SomaLogic received $60.5 million in funding from Visium Healthcare Partners.
Transaction Overview
Company Name
Announced On
3/1/2016
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$60,500,000
Round
Undisclosed
Investors
Visium Healthcare Partners (Avi Amin)
Proceeds Purpose
The proceeds will be used to support SomaLogic's continued growth, including its primary focus on the development of novel life science tools and clinical diagnostics based on the Company's proprietary proteomics technology.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2945 Wilderness Pl.
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Overview
SomaLogic, Inc. is developing novel proteomics systems and applications based on its proprietary aptamer technology. Aptamers are single-stranded DNA and RNA molecules that, like antibodies, can bind to target molecules with high affinity and specificity.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Roy Smythe
Chief Medical Officer
Stephen Williams
Chief Operating Officer
Alan Williams
Chief Scientific Officer
Nebojsa Janjic
President
Melody Harris
Browse more venture capital transactions:
Prev: 3/1/2016: Miramar Labs venture capital transaction
Next: 3/1/2016: Hungryroot venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs